- Home
- USLM vs RCKT Comparison
USLM vs RCKT Comparison
Compare USLM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- RCKT
- Stock Information
- Founded
- USLM 1948
- RCKT 1999
- Country
- USLM United States
- RCKT United States
- Employees
- USLM N/A
- RCKT N/A
- Industry
- USLM Other Metals and Minerals
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- RCKT Health Care
- Exchange
- USLM Nasdaq
- RCKT Nasdaq
- Market Cap
- USLM 2.8B
- RCKT 326.4M
- IPO Year
- USLM N/A
- RCKT N/A
- Fundamental
- Price
- USLM $102.43
- RCKT $2.88
- Analyst Decision
- USLM
- RCKT Buy
- Analyst Count
- USLM 0
- RCKT 13
- Target Price
- USLM N/A
- RCKT $18.50
- AVG Volume (30 Days)
- USLM 219.6K
- RCKT 4.5M
- Earning Date
- USLM 07-30-2025
- RCKT 08-04-2025
- Dividend Yield
- USLM 0.23%
- RCKT N/A
- EPS Growth
- USLM 50.52
- RCKT N/A
- EPS
- USLM 4.20
- RCKT N/A
- Revenue
- USLM $337,287,000.00
- RCKT N/A
- Revenue This Year
- USLM $21.67
- RCKT N/A
- Revenue Next Year
- USLM $13.19
- RCKT N/A
- P/E Ratio
- USLM $24.32
- RCKT N/A
- Revenue Growth
- USLM 17.83
- RCKT N/A
- 52 Week Low
- USLM $65.45
- RCKT $2.19
- 52 Week High
- USLM $159.53
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- USLM 55.19
- RCKT 41.23
- Support Level
- USLM $96.90
- RCKT $2.40
- Resistance Level
- USLM $104.56
- RCKT $2.70
- Average True Range (ATR)
- USLM 3.55
- RCKT 0.22
- MACD
- USLM 0.20
- RCKT 0.13
- Stochastic Oscillator
- USLM 79.79
- RCKT 60.76
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.